TUBERCULOSIS: US approves Bedaquiline treatment for drug-resistant TB

ck

Tuberculosis has developed a growing resistance to the antibiotics used to combat it, and with fatal consequences Regulators in the United States have now approved a drug that can treat a drug-resistant strain of TB. It is the first new medication against TB to be registered for more than 40 years. Despite long-lasting side effects, it may be the lesser of two evils for people diagnosed with a potentially lethal form of TB. Al Jazeera's Dominic Kane reports.